Growth Metrics

Silence Therapeutics (SLN) Leases (2023 - 2026)

Silence Therapeutics recorded quarterly Leases of $142000.0 in Q1 2026, down 14.97% quarter-over-quarter from $167000.0 in Q4 2025, and up 32.71% year-over-year from $107000.0 in Q1 2025.

Silence Therapeutics' Leases history runs 4 years deep, the most recent figure standing at $142000.0 for Q1 2026.

  • In Q1 2026, Leases rose 32.71% year-over-year to $142000.0; the TTM figure through Mar 2026 stood at $142000.0 (up 32.71% YoY), while the FY2025 annual figure was $167000.0, up 6.37% from the prior year.
  • Leases came in at $142000.0 for Q1 2026 at Silence Therapeutics, down from $167000.0 in the prior quarter.
  • In the past five years, Leases ranged from a high of $370000.0 in Q4 2023 to a low of $58000.0 in Q2 2025.
  • A 4-year average of $170428.6 and a median of $157000.0 in 2024 frame the typical range for Leases.
  • Across the five-year window, Leases plunged 57.57% in 2024 and jumped 32.71% in 2026, its largest moves.
  • Silence Therapeutics' Leases stood at $370000.0 in 2023, then slumped by 57.57% to $157000.0 in 2024, then grew by 6.37% to $167000.0 in 2025, then dropped by 14.97% to $142000.0 in 2026.
  • According to Business Quant data, Leases over the past three periods registered $142000.0, $167000.0, and $192000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Leases (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 83,048.00
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 61,822.50
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 285.20 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 1.69 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 189.30 Mn
10 Silence Therapeutics 924.61 Mn 854.53 Mn 411,000.00 142,000.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 142,000.00
Dec 31, 2025 167,000.00
Sep 30, 2025 192,000.00
Jun 30, 2025 58,000.00
Mar 31, 2025 107,000.00
Dec 31, 2024 157,000.00
Dec 31, 2023 370,000.00